Carret Asset Management LLC purchased a new stake in shares of PerkinElmer, Inc. (NYSE:PKI) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 3,080 shares of the medical research company’s stock, valued at approximately $210,000.

A number of other hedge funds also recently made changes to their positions in PKI. Waldron LP purchased a new position in PerkinElmer during the first quarter valued at approximately $233,000. Russell Investments Group Ltd. raised its position in PerkinElmer by 13.4% during the first quarter. Russell Investments Group Ltd. now owns 21,459 shares of the medical research company’s stock valued at $1,245,000 after acquiring an additional 2,531 shares in the last quarter. UBS Asset Management Americas Inc. raised its position in PerkinElmer by 15.0% during the first quarter. UBS Asset Management Americas Inc. now owns 73,057 shares of the medical research company’s stock valued at $4,242,000 after acquiring an additional 9,507 shares in the last quarter. Mutual of America Capital Management LLC raised its position in PerkinElmer by 1.5% during the first quarter. Mutual of America Capital Management LLC now owns 13,020 shares of the medical research company’s stock valued at $756,000 after acquiring an additional 190 shares in the last quarter. Finally, Ameritas Investment Partners Inc. purchased a new position in PerkinElmer during the first quarter valued at approximately $152,000. Institutional investors own 91.47% of the company’s stock.

Several research analysts recently weighed in on the company. Morgan Stanley reiterated an “overweight” rating and set a $77.00 price target (down from $79.00) on shares of PerkinElmer in a research report on Friday. Cantor Fitzgerald reiterated a “hold” rating on shares of PerkinElmer in a research report on Sunday, July 16th. Zacks Investment Research upgraded PerkinElmer from a “hold” rating to a “buy” rating and set a $78.00 price target for the company in a research report on Wednesday, July 19th. Piper Jaffray Companies lifted their price target on PerkinElmer to $80.00 and gave the company an “overweight” rating in a research report on Tuesday, July 25th. Finally, Wells Fargo & Company started coverage on PerkinElmer in a research report on Thursday, July 13th. They issued a “market perform” rating and a $72.00 price objective for the company. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and five have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $67.77.

TRADEMARK VIOLATION WARNING: “Carret Asset Management LLC Invests $210,000 in PerkinElmer, Inc. (PKI) Stock” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/10/08/carret-asset-management-llc-invests-210000-in-perkinelmer-inc-pki-stock.html.

Shares of PerkinElmer, Inc. (NYSE PKI) traded up 0.34% during mid-day trading on Friday, hitting $70.61. The stock had a trading volume of 300,596 shares. The stock has a 50 day moving average price of $67.73 and a 200-day moving average price of $64.36. PerkinElmer, Inc. has a 52-week low of $45.35 and a 52-week high of $70.61. The company has a market cap of $7.78 billion, a PE ratio of 21.29 and a beta of 0.72.

PerkinElmer (NYSE:PKI) last released its quarterly earnings data on Thursday, August 3rd. The medical research company reported $0.67 earnings per share for the quarter, meeting the consensus estimate of $0.67. PerkinElmer had a return on equity of 13.44% and a net margin of 16.80%. The firm had revenue of $547.00 million during the quarter, compared to the consensus estimate of $554.14 million. During the same period last year, the business posted $0.67 EPS. PerkinElmer’s quarterly revenue was up 2.0% on a year-over-year basis. On average, equities analysts expect that PerkinElmer, Inc. will post $2.89 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 10th. Investors of record on Friday, October 20th will be paid a $0.07 dividend. This represents a $0.28 annualized dividend and a yield of 0.40%. The ex-dividend date is Thursday, October 19th. PerkinElmer’s payout ratio is currently 8.46%.

PerkinElmer Company Profile

PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.

Want to see what other hedge funds are holding PKI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PerkinElmer, Inc. (NYSE:PKI).

Institutional Ownership by Quarter for PerkinElmer (NYSE:PKI)

Receive News & Stock Ratings for PerkinElmer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer Inc. and related stocks with our FREE daily email newsletter.